Veeva Systems Inc.

$19.00

SKU: VEEV Category:

Description

This is our first report on Veeva Systems, one of the well-known providers of cloud-based software solutions for the global life sciences industry. The company had a strong quarter, delivering results ahead of its guidance as well as beyond Wall Street expectations in terms of revenues as well as earnings. The total subscription revenue has been growing despite the macroeconomic environment and the innovative engine of the company is also strong. The growth of R&D solutions in the quarter was also impressive. The fact remains that bulk of the revenue of Veeva is on the application of Veeva Vault. The management announced that it is moving Veena CRM to the platform of Veena Vault over time which will allow the company to deliver a better customer experience and better application. Another good news is that its strategic partnerships within the industry is increasing as well. They recently announced a strategic partnership agreement of ten-year with Merck. We initiate coverage on the stock of Veeva Systems with a ‘Hold’ rating.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!